Health Midwest Ventures Group, Inc d/b/a HCA MidAmerica Division, LLC

Kansas City, Missouri 64132

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Triple Negative Breast Cancer

Studies at this site

• DS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has Spread [DESTINY-Breast02] — Completed
• A Study of Atezolizumab in Combination With Nab-Paclitaxel Compared With Placebo With Nab-Paclitaxel for Participants With Previously Untreated Metastatic Triple-Negative Breast Cancer (IMpassion130) — Completed